Finance

Lists
Why is ABNX down 2,04%?
Dive Deeper
ABNX:EPA
Abionyx Pharma SA
€1,64
-2,04%
(-0,034) 1D
16 Nov., 17:35:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABNX...
Open
€1,67
High
€1,67
Low
€1,61
Mkt. cap
72,09 m
Avg. vol.
117,54 k
Volume
93,15 k
52-wk high
€4,53
52-wk low
€1,41
EPS
-€0,23
Shares outstanding
44,07 m
No. of employees
49
Open
€1,67
High
€1,67
Low
€1,61
Mkt. cap
72,09 m
Avg. vol.
117,54 k
Volume
93,15 k
52-wk high
€4,53
52-wk low
€1,41
EPS
-€0,23
Shares outstanding
44,07 m
No. of employees
49
News stories
From web sources and news partners
About Abionyx Pharma SA
CEOCyrille Tupin
Employees49
Founded2005
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
1,06 m
1,06 m
972,00 k
972,00 k
Cost of goods sold
945,50 k
945,50 k
819,00 k
819,00 k
Cost of revenue
945,50 k
945,50 k
819,00 k
819,00 k
Research and development expenses
346,00 k
346,00 k
413,00 k
413,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
938,00 k
938,00 k
1,35 m
1,35 m
Operating expense
1,28 m
1,28 m
1,76 m
1,76 m
Total operating expenses
2,22 m
2,22 m
2,58 m
2,58 m
Operating income
-1,16 m
-1,16 m
-1,60 m
-1,60 m
Other non operating income
11,00 k
11,00 k
-19,00 k
-19,00 k
EBT including unusual items
-1,15 m
-1,15 m
-1,62 m
-1,62 m
EBT excluding unusual items
-1,15 m
-1,15 m
-1,62 m
-1,62 m
Income tax expense
4,00 k
4,00 k
500,00
500,00
Effective tax rate
-0,35%
-0,35%
-0,03%
-0,03%
Other operating expenses
-5,00 k
-5,00 k
-5,00 k
-5,00 k
Net income
-1,15 m
-1,15 m
-1,62 m
-1,62 m
Net profit margin
-108,82%
-108,82%
-166,87%
-166,87%
Earnings per share
-
-
-
-
Interest and investment income
8,50 k
8,50 k
18,50 k
18,50 k
Interest expense
-26,50 k
-26,50 k
-16,00 k
-16,00 k
Net interest expenses
-18,00 k
-18,00 k
2,50 k
2,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,13 m
-1,13 m
-1,58 m
-1,58 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme